Senzime (STO: SEZI; OTCQX: SNZZF) has announced the launch of its TetraSens electromyography (EMG) sensor for use with the TetraGraph Train-of-Four monitoring system for anesthesia monitoring.
According to Senzime, the new sensor is designed and manufactured with focus on sustainability, performance and usability. It is now commercially available in European markets and will be introduced in the U.S. during Q3 2026.
In a statement, Philip Siberg, CEO of Senzime, commented, “We continue to pioneer our industry through performance advancements that drive patient safety, cost reductions, and environmental responsibility. The new TetraSens marks another important advancement for Senzime incorporating learnings from more than a million cases and responding to healthcare providers’ increasing demand for more sustainable medical products.”
